Pharmaceutical manufacturing

FILE - This Sept. 30, 2019 file photo shows a box of Zantac tablets at a pharmacy in Miami Beach, Fla. On Wednesday, April 1, 2020, U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The warning applies to all prescription and over-the-counter versions of ranitidine, best known by the brand name Zantac. (AP Photo/Wilfredo Lee, File)
April 01, 2020 - 3:25 pm
WASHINGTON (AP) — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The move from the Food and Drug Administration Wednesday...
Read More
FILE - In this Nov. 28, 2018, file photo, the Department of Justice seal is seen in Washington, D.C. An internet firm is ending the automated registration of website names that include words or phrases related to the COVID-19 pandemic, in an attempt to combat coronavirus-related fraud. Los Angeles-based Namecheap Inc. made the pledge after a federal judge in Texas on Sunday, March 22, 2020, ordered the takedown of a website the U.S. Department of Justice accused of stealing credit card information while offering fake coronavirus vaccine kits. (AP Photo/Jose Luis Magana, File)
March 26, 2020 - 6:31 pm
BOSTON (AP) — An internet firm is ending the automated registration of website names that include words or phrases related to the COVID-19 pandemic, an attempt to combat coronavirus-related fraud. Los Angeles-based Namecheap Inc. made the pledge after a federal judge in Texas ordered the takedown...
Read More
In this photo released by Saudi Press Agency, SPA, Saudi King Salman, chairs a video call of world leaders from the Group of 20 and other international bodies and organizations, from his office in Riyadh, Saudi Arabia, Thursday, March 26, 2020. The meeting is aimed at coordinating the global response to the fast-spreading coronavirus, which has shuttered businesses and forced well over a quarter of the world's population into home isolation. (Saudi Press Agency via AP)
March 26, 2020 - 6:01 pm
DUBAI, United Arab Emirates (AP) — The head of the United Nations told leaders of the world’s 20 major industrialized nations during an emergency virtual summit Thursday that "we are at war with a virus — and not winning it” despite dramatic measures by countries to seal their borders, shutter...
Read More
FILE - In this July 9, 2015, file photo, a man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences said Wednesday, March 25, 2020 it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment. (AP Photo/Eric Risberg, File)
March 25, 2020 - 3:55 pm
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment. Gilead Sciences said it will ask U.S. regulators to revoke the so-...
Read More
FILE - In this Monday, March 2, 2020 file photo, Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington. Gilead, the pharmaceutical giant that makes remdesivir, a promising coronavirus drug, has registered it as a rare disease treatment with U.S. regulators on Monday, March 23, 2020, a status that can potentially be worth millions in tax breaks and competition-free sales. (AP Photo/Andrew Harnik)
March 24, 2020 - 9:11 pm
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales. What that specialty status will actually mean for the...
Read More
FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. On Tuesday, March 24, 2020, the U.S. Food and Drug Administration warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions. (AP Photo/Rich Pedroncelli, File)
March 24, 2020 - 6:21 pm
U.S. regulators on Tuesday warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions. The Food and Drug Administration issued the warning after drugmakers Pfizer and Mylan told medical providers that the problems could cause death or serious...
Read More
President Donald Trump speaks during a meeting with tourism industry executives about the coronavirus, in the Cabinet Room of the White House, Tuesday, March 17, 2020, in Washington. (AP Photo/Evan Vucci)
March 18, 2020 - 8:47 am
WASHINGTON (AP) — President Donald Trump has sent lawmakers a $46 billion emergency funding request to help the government fight the coronavirus and to reverse cuts proposed just last month to the Centers for Disease Control, the front-line agency in fighting the battle. The huge request, delivered...
Read More
People walk past a convenient store where the latest cover of a magazine is stuck on a pillar outside of it on Sunday, March 15, 2020, in New York. President Donald Trump on Sunday called on Americans to cease hoarding groceries and other supplies, while one of the nation's most senior public health officials called on the nation to act with more urgency to safeguard their health as the coronavirus outbreak continued to spread across the United States. (AP Photo/Wong Maye-E)
March 16, 2020 - 6:52 pm
Millions of people are stocking up and holing up at home a as a growing number of governments fight to bring the coronavirus under control. The number of reported cases worldwide topped 175,000 with 6,700 deaths. More than 77,000 people have recovered from the illness. These are some of the latest...
Read More
A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren)
March 16, 2020 - 5:03 pm
SEATTLE (AP) — U.S. researchers gave the first shots in a first test of an experimental coronavirus vaccine Monday, leading off a worldwide hunt for protection even as the pandemic surges. With careful jabs in the arms of four healthy volunteers, scientists at the Kaiser Permanente Washington...
Read More
March 16, 2020 - 11:06 am
BERLIN (AP) — A German company working on a potential vaccine for the new coronavirus denied reports Monday that the U.S. government was angling to acquire it, while German officials sought to ease tensions fueled by the story by insisting the firm would stay in the country. On Sunday, Germany's...
Read More

Pages